Feb. 3 at 10:39 PM
$IGC
"IGC Pharma director reports RSU conversion into common stock. On January 19, 2026, director Richard K. Prins exercised 100,000 restricted stock units, which were granted on March 13, 2024 and vest when specific board-approved milestones are achieved. Each unit represents the right to receive one share of IGC common stock, and the transaction was reported at an exercise price of
$0.0 per unit. Following this transaction, Prins directly holds 1,371,251 shares of common stock and 50,000 restricted stock units".
